The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Promoting Chinese Herbal Drugs through Regulatory Globalisation
Open accessAbstract
This study explores the social dynamics in promoting traditional Chinese medicine (tcm) drugs by making them acceptable to biomedical markets. It investigates the Consortium for Globalization of Chinese Medicine (cgcm), an organisation based in Hong Kong in pursuit of advancing tcm, and traces the development of the herbal formula phy 906, a Chinese herbal product intensively discussed at the cgcm that has been tested according to the us Food and Drug Administration’s regulation for approval. Departing from accounts on the organisation’s success that focus either on its scientific approach or its leader Yung-chi Cheng, this paper argues that it was the synergy between the cgcm and the pursuit of approval for phy 906 that contributed to the regulatory globalisation of tcm. In this process, not only organisations like the cgcm are required to streamline efforts for producing globalised tcm; also researchers are needed who, with cultural commitment, seek for transforming tcm to meet biomedical indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An illustrative case is that of the botanical Phy906, which has passed the USFDA's phase II trials as an adjuvant in several cancer therapies.”
From Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market: A Critical Assessment (2019) · cites this paper as Kuo 2015
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Wen-Hua Kuo's ethnography shows how the excitement over the drug gradually declined as it was dragged through a fifteen-year-long regulatory journey from innovation to publication of its phase II results in 2014.”
From Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market: A Critical Assessment (2019) · cites this paper as Kuo 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pordié, L., & Gaudillière, J.-P. (2014) · East Asian Science, Technology and Society: An International Journal · doi:10.1215/18752160-2406053 · Cited by 84
Research works printed but not linked: 21
- Chen, 2008, ‘New Therapies from Old Medicines’, Nature Biotechnology, 16, 1077, 10.1038/nbt1008-1077 · DOI · Paper page
- 2001, ‘Conversations between Chief Executive Chee-hwa Tung and Legislative Council Members’, China.org.cn
- Farrell, 2003, ‘Phase i/iia Randomized Study of phy906, a Novel Herbal Agent, as a Modulator of Chemotherapy in Patients with Advanced Colorectal Cancer’, Clinical Colorectal Cancer, 2, 253, 10.3816/CCC.2003.n.007 · DOI
- Fischer, 2012, ‘Dr Judah Folkman’s Decalogue and Network Analysis’, 339
- Furth, 2011, ‘The AMS/Paterson Lecture: Becoming Alternative? Modern Transformations of Chinese Medicine in China and in the United States’, Canadian Bulletin of Medical History/Bulletin canadien d’histoire de la medicine, 28, 5, 10.3138/cbmh.28.1.5 · DOI · Paper page
- Hanson, 2015, ‘Is the 2015 Nobel Prize a Turning Point for Traditional Chinese Medicine?’, The Conversation
- Jasanoff, 2004, ‘The Idiom of Co-Production’, 6, 10.4324/9780203413845 · DOI · Paper page
- Jasanoff, 2011, ‘The Practices of Objectivity in Regulatory Science’, 307
- Kuo, 2009, ‘Bridging Studies in Japan and Taiwan: A Dynamic Evolution in Regulating Ethnic Differences’, Drug Information Journal (sci), 43, 3, 10.1177/009286150904300102 · DOI
- Lam, 2015, ‘Lessons from the Development of the Traditional Chinese Medicine Formula phy906’, Science, 347, S43
- Liu, 2012, ‘Old Formula, New Rx: The Journey of phy906 as Cancer Adjuvant Therapy’, Journal of Ethnopharmacology, 140, 614, 10.1016/j.jep.2012.01.047 · DOI
- Liu, 2001, ‘A Chinese Medicine Formulation, phy906 Can Enhance the Therapeutic Index of CPT-Il and Other Anticancer Drugs against Cancer in Mice’, American Association for Cancer Research, 41, 458
- Liu, 2002, ‘Botanical Activity Relationship in Traditional Chinese Medicine: Studies of phy906 as an Adjuvant Therapy with Cancer Chemotherapeutic Agents’, Proceedings of American Association for Cancer Research, 43, 4758
- Liu, 2000, ‘Prevention of CPT-Il Induced Toxicity by a Chinese Medicinal Formulation, phy-906’, American Association for Cancer Research, 41, 2608
- Lock, 2010, ‘Anthropologies of Medicine’, 57
- Saif, 2010a, ‘Phase I Study of the Botanical Formulation phy906 with Capecitabine in Advanced Pancreatic and Other Gastrointestinal Malignancies’, Phytomedicine, 17, 161, 10.1016/j.phymed.2009.12.016 · DOI
- Saif, 2010b, ‘Phase II Study of phy906 plus Capecitabine (CAP) in PTS with Gemcitabine-Refractory Pancreatic Cancer (PC) and Measurement of Cytokines’, Journal of Clinical Oncology, 28, e14540, 10.1200/jco.2010.28.15_suppl.e14540 · DOI
- Saif, 2014, ‘First-in-human Phase II Trial of the Botanical Formulation phy906 with Capecitabine as Second-line Therapy in Patients with Advanced Pancreatic Cancer’, Cancer Chemotherapy Pharmacology, 73, 373, 10.1007/s00280-013-2359-7 · DOI
- Teng, 2014, ‘Review and Prospects of Taiwan’s tcm research’ [台灣中草藥研究回顧與展望]
- Yin, 2013, ‘Therapeutic Applications of Herbal Medicines for Cancer Patients’, Evidence-Based Complementary and Alternative Medicine, Volume 2013, 10.1155/2013/302426 · DOI
- Zhan, 2009, Other-Worldly: Making Chinese Medicine through Transnational Frames, 10.1215/9780822392132 · DOI
Cited by
Sorted by citations
Indian Imaginaries of Chinese Success in the Global Herbal Medicine Market: A Critical Assessment
Kudlu, C., & Nichter, M. (2019) · Asian Medicine · doi:10.1163/15734218-12341437 · Cited by 7
Metadata
- Authors
- Kuo, W.-H.
- Affiliations
- National Yang Ming University (TW)
- Corresponding author
- Kuo, Wen-Hua
- Venue
- Asian Medicine
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-10-03
- Volume
- 10
- Issue
- 1-2
- Pages
- 316-339
- ISSN
- 1573-420X (ISSN-L)
- 1573-4218
- OpenAlex
- W2549150190
- Cited by
- 12
- References
- 1
- Citations by year
- 2025: 1 · 2021: 10 · 2017: 1
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Asian Medicine (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Herbal Medicine and Trade Cooperation
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Studies
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- traditional Chinese medicine, Chinese herbal medicine, herbal formula, FDA drug approval, social dynamics, cultural commitment, Hong Kong
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Promoting Chinese Herbal Drugs through Regulatory Globalisation. https://app.cochat.ai/papers/10.1163/15734218-12341351
- The paper
- Kuo, W.-H. (2015). Promoting Chinese Herbal Drugs through Regulatory Globalisation. Asian Medicine. https://doi.org/10.1163/15734218-12341351
